ImClone to announce sale talks continuing: report
(Reuters) - ImClone Systems Inc is expected to announce later on Monday that it is continuing talks to sell itself to a major pharmaceutical concern for a price in the range of $6.1 billion, the Wall Street Journal said, citing people familiar with the matter.
<p><img src="http://feeds.reuters.com/~a/reuters/businessNews?i=RR8Meb" border="0"></img> (http://feeds.reuters.com/~a/reuters/businessNews?a=RR8Meb)</p><div class="feedflare">
<img src="http://feeds.reuters.com/~f/reuters/businessNews?i=gnPiL" border="0"></img> (http://feeds.reuters.com/~f/reuters/businessNews?a=gnPiL) <img src="http://feeds.reuters.com/~f/reuters/businessNews?i=h79Ql" border="0"></img> (http://feeds.reuters.com/~f/reuters/businessNews?a=h79Ql) <img src="http://feeds.reuters.com/~f/reuters/businessNews?i=q6Yvl" border="0"></img> (http://feeds.reuters.com/~f/reuters/businessNews?a=q6Yvl)
</div><img src="http://feeds.reuters.com/~r/reuters/businessNews/~4/405960983" height="1" width="1"/>
http://feeds.reuters.com/~r/reuters/businessNews/~3/405960983/idUSTRE48S0QO20080929